Blog
Archive
July 24, 2026
The EU AI Act's New Timeline: What the Digital Omnibus Means for AI-Enabled Medical Devices
July 19, 2026
The FDA at 120: What 120 Years of Regulatory History Means for SaMD, AI, and XR Developers
July 16, 2026
EN 18286 Passes the Formal Vote: What the First EU AI Act QMS Standard Means for AI/ML Device Makers
July 16, 2026
Validating Medical Device Cybersecurity Through Penetration Testing: What MDIC's New Best Practices Mean for Developers
July 16, 2026
Validating AI Segmentation Without a Gold Standard: A New FDA Method and What It Means for Developers
July 16, 2026
FDA Finalizes Human Factors Content Guidance for Marketing Submissions: What It Means and Why It Matters
May 12, 2025
Designing Your Software Medical Device (SaMD) Verification and Validation Plan, Protocol, and Report
May 12, 2025
How to create a Threat Model and Vulnerability Assessment to comply with FDA cybersecurity expectations.
July 1, 2024
Leveraging Computational Modeling for Medical Device Premarket Submissions: A Comprehensive Guide
June 26, 2024
FDA Guidance on Digital Health Devices For Treating Psychiatric Disorders during COVID-19
June 25, 2024
FDA Greenlights Revolutionary Skin Cancer Detection Device and the Regulatory Implications for Future AI/ML-enabled devices
June 25, 2024
